awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47113773-461590C5-21E4-4D8E-A8E4-6B3537A8A334
Q47113773-461590C5-21E4-4D8E-A8E4-6B3537A8A334
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47113773-461590C5-21E4-4D8E-A8E4-6B3537A8A334
XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose.
P2860
Q47113773-461590C5-21E4-4D8E-A8E4-6B3537A8A334
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47113773-461590C5-21E4-4D8E-A8E4-6B3537A8A334
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
84d3b80fc06a0eed9b5593cc4874a9e48f23e448
P2860
Role of receptor occupancy assays by flow cytometry in drug development.